GS0051: Pharmaceuticals, namely, energy-activated compounds used for treatment in the areas of oncology, ophthalmology, cardiovascular systems, infectious diseases, and adipose tissue reduction
Case File Event Statements
3/29/2006 - 18 years ago
29 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDType:MAB6
3/29/2006 - 18 years ago
28 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
7/20/2005 - 19 years ago
27 - EXTENSION 5 GRANTEDType:EX5G
7/20/2005 - 19 years ago
26 - EXTENSION 5 FILEDType:EXT5
7/20/2005 - 19 years ago
25 - TEAS EXTENSION RECEIVEDType:EEXT
2/8/2005 - 19 years ago
24 - EXTENSION 4 GRANTEDType:EX4G
1/21/2005 - 19 years ago
23 - EXTENSION 4 FILEDType:EXT4
1/25/2005 - 19 years ago
22 - EXTENSION RECEIVED WITH TEAS PETITIONType:TPEX
1/25/2005 - 19 years ago
21 - PETITION TO REVIVE-GRANTEDType:PETG
1/25/2005 - 19 years ago
20 - TEAS PETITION TO REVIVE RECEIVEDType:PROA
8/14/2004 - 20 years ago
19 - EXTENSION 3 GRANTEDType:EX3G
7/21/2004 - 20 years ago
18 - EXTENSION 3 FILEDType:EXT3
7/29/2004 - 20 years ago
17 - CASE FILE IN TICRSType:CFIT
7/21/2004 - 20 years ago
16 - TEAS EXTENSION RECEIVEDType:EEXT
2/5/2004 - 20 years ago
15 - EXTENSION 2 GRANTEDType:EX2G
1/14/2004 - 21 years ago
14 - EXTENSION 2 FILEDType:EXT2
1/14/2004 - 21 years ago
13 - TEAS EXTENSION RECEIVEDType:EEXT
7/28/2003 - 21 years ago
12 - EXTENSION 1 GRANTEDType:EX1G
7/17/2003 - 21 years ago
11 - EXTENSION 1 FILEDType:EXT1
7/17/2003 - 21 years ago
10 - TEAS EXTENSION RECEIVEDType:EEXT
2/5/2003 - 21 years ago
9 - TEAS CHANGE OF CORRESPONDENCE RECEIVEDType:TCCA
1/21/2003 - 21 years ago
8 - NOA MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
11/13/2002 - 22 years ago
7 - PAPER RECEIVEDType:MAIL
10/29/2002 - 22 years ago
6 - PUBLISHED FOR OPPOSITIONType:PUBO
10/9/2002 - 22 years ago
5 - NOTICE OF PUBLICATIONType:NPUB
8/12/2002 - 22 years ago
4 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA